These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38917518)

  • 1. Solitary Tumefactive Demyelinating Lesions in Children: Clinical and Magnetic Resonance Imaging Features, Pathologic Characteristics, and Outcomes.
    Frankl S; Viaene A; Vossough A; Waldman A; Hopkins S; Banwell B
    Pediatr Neurol; 2024 Aug; 157():141-150. PubMed ID: 38917518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
    Yiu EM; Laughlin S; Verhey LH; Banwell BL;
    J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
    Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
    J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.
    Hanumanthe SB; Francisco C; Hart J; Graves J; Waubant E
    J Child Neurol; 2016 Dec; 31(14):1528-1533. PubMed ID: 27572815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.
    Barbosa BC; Marchiori E; Leal Leidersnaider C; Brandao L; Castillo M
    Neuroradiol J; 2019 Apr; 32(2):103-107. PubMed ID: 30667319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solitary tumefactive demyelinating lesions in children.
    Morin MP; Patenaude Y; Sinsky AB; Banwell B; Sébire G
    J Child Neurol; 2011 Aug; 26(8):995-9. PubMed ID: 21555780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumefactive demyelinating lesion: experience with two unusual patients.
    Sinha MK; Garg RK; Bhatt ML; Chandra A
    J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology.
    Saridas F; Mesut G; Ceylan CY; Ozpar R; Ozsen M; Koc ER; Tolunay S; Hakyemez B; Turan OF
    Mult Scler Relat Disord; 2024 May; 85():105537. PubMed ID: 38460252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.
    Cha S; Pierce S; Knopp EA; Johnson G; Yang C; Ton A; Litt AW; Zagzag D
    AJNR Am J Neuroradiol; 2001; 22(6):1109-16. PubMed ID: 11415906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumefactive Demyelinating Lesions in Children: A Rare Case of Conus Medullaris Involvement and Systematic Review of the Literature.
    Pérez CA; Patnaik A; Oommen S; Redko A; Mathis SB
    J Child Neurol; 2020 Sep; 35(10):690-699. PubMed ID: 32552343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric tumefactive demyelination: case series and review of the literature.
    McAdam LC; Blaser SI; Banwell BL
    Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of 18F-FET PET in Patients With Suspected Tumefactive Demyelinating Disease-Preliminary Experience From a Retrospective Analysis.
    Barbagallo M; Albatly AA; Schreiner S; Hayward-Könnecke HK; Buck A; Kollias SS; Huellner MW
    Clin Nucl Med; 2018 Nov; 43(11):e385-e391. PubMed ID: 30153143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumefactive demyelinating lesions: A literature review of recent findings.
    Al Malik YM
    Neurosciences (Riyadh); 2024 Jul; 29(3):153-160. PubMed ID: 38981633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
    Ongphichetmetha T; Aungsumart S; Siritho S; Apiwattanakul M; Tanboon J; Rattanathamsakul N; Prayoonwiwat N; Jitprapaikulsan J
    Sci Rep; 2024 Jan; 14(1):1426. PubMed ID: 38228919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma?
    Hiremath SB; Muraleedharan A; Kumar S; Nagesh C; Kesavadas C; Abraham M; Kapilamoorthy TR; Thomas B
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):685-690. PubMed ID: 28209583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumefactive demyelination: clinical, imaging and follow-up observations in thirty-nine patients.
    Nagappa M; Taly AB; Sinha S; Bharath RD; Mahadevan A; Bindu PS; Saini JS; Prasad C; Shankar SK
    Acta Neurol Scand; 2013 Jul; 128(1):39-47. PubMed ID: 23277913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumefactive Multiple Sclerosis: The Lethal Chameleon.
    Monteiro AC; de Santana TF; Chumbo C; Negrão C; Valido T; Figueiredo F; Matos C
    Eur J Case Rep Intern Med; 2024; 11(9):004779. PubMed ID: 39279988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
    Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
    Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.